SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 137 filers reported holding SUTRO BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $76,945 | -48.0% | 26,261 | +0.2% | 0.00% | – |
Q1 2024 | $148,030 | +12.7% | 26,200 | -14.4% | 0.00% | – |
Q4 2023 | $131,377 | +77.0% | 30,624 | +43.2% | 0.00% | – |
Q3 2023 | $74,209 | -26.7% | 21,386 | -1.8% | 0.00% | – |
Q2 2023 | $101,287 | +12.8% | 21,782 | +12.0% | 0.00% | – |
Q1 2023 | $89,826 | -82.3% | 19,443 | -69.0% | 0.00% | – |
Q4 2022 | $506,939 | +54.1% | 62,740 | +5.8% | 0.00% | – |
Q3 2022 | $329,000 | +2.8% | 59,302 | -3.3% | 0.00% | – |
Q2 2022 | $320,000 | -28.1% | 61,318 | +13.3% | 0.00% | – |
Q1 2022 | $445,000 | -82.0% | 54,131 | -67.4% | 0.00% | -100.0% |
Q4 2021 | $2,474,000 | -62.1% | 166,222 | -51.9% | 0.00% | -50.0% |
Q3 2021 | $6,520,000 | +4.3% | 345,237 | +2.7% | 0.00% | 0.0% |
Q2 2021 | $6,252,000 | -6.3% | 336,290 | +14.8% | 0.00% | 0.0% |
Q1 2021 | $6,670,000 | +357.2% | 293,033 | +336.1% | 0.00% | – |
Q4 2020 | $1,459,000 | – | 67,193 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |